Immix Biopharma, Inc.'s total assets for Q were $22.47M, an increase of 44.38% from the previous quarter. IMMX total liabilities were $2.83M for the fiscal quarter, a 17.93% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.